Login / Signup

MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.

Stephanie B Syc-MazurekHannah Zhao-FlemingYong GuoNanthaya TisavipatJohn J ChenAnastasia ZekeridouIoannis KournoutasJacob J OrmeMatthew S BlockClaudia F LucchinettiRafid MustafaEoin Patrick Flanagan
Published in: Neurology(R) neuroimmunology & neuroinflammation (2024)
This case revealed a presentation of MOGAD concurrent with melanoma without tumor MOG immunostaining. We highlight tocilizumab as a dual-purpose treatment of MOGAD and the neurologic immune-related adverse effect of ICI.
Keyphrases
  • rheumatoid arthritis
  • squamous cell carcinoma
  • case report
  • juvenile idiopathic arthritis
  • locally advanced
  • rheumatoid arthritis patients
  • systemic lupus erythematosus